Participants completed online surveys on health, demographics, modifiable dementia risk factors via a customized Dementia Risk Profile (DRP) tool and provided blood samples for APOE genotyping and plasma phosphorylated-tau (p-tau). The gene discussed is APOE; the disease is dementia.